Search results
21 mar 2021 · An intrauterine device, or IUD, that releases the hormone levonorgestrel appears to be an effective treatment for endometrial precancer and early-stage endometrial cancer, according to new study results presented by Andreas Obermair, MD, at the Society of Gynecologic Oncology (SGO) 2021 Virtual Annual Meeting on Women’s Cancer (Abstract ID ...
22 gru 2022 · The Cu-IUD has been associated with reductions in both endometrial mitotic activity and estrogen receptor concentrations, which inhibits endometrial growth, offering protection against EC. 6 Both Cu-IUDs and hormonal IUDs cause chronic uterine inflammation, which reduces endometrial hyperplasia. 34
18 paź 2009 · However, the levonorgestrel-containing IUD may be preferable for women being treated with tamoxifen and women who have survived non-hormonally mediated cancers. Women with IUDs can undergo all forms of imaging, including computed tomography and magnetic resonance imaging.
12 kwi 2021 · Women diagnosed with precancerous endometrial hyperplasia or early-stage endometrial cancer may benefit from the use of a hormonal intrauterine device (IUD), an implant that prevents pregnancy by releasing the contraceptive levonorgestrel. Endometrial cancer is a form of uterine cancer.
21 sty 2016 · For example, a non-hormonal intrauterine device (IUD) is a reversible form of birth control that is not linked to breast cancer. Bonus: It might also lower your risk of cervical and endometrial cancer.
22 mar 2021 · An intrauterine device (IUD) that releases the hormone levonorgestrel has shown promise as an effective treatment for endometrial precancer and early-stage endometrial cancer. Results of the study are being presented at the Society of Gynecologic Oncology (SGO) 2021 Virtual Annual Meeting on Women’s Cancer.
This meta-analysis provides valuable insights into the effectiveness of oral progestins and LNG-IUD treatment within a 12-month timeframe for patients with early-stage endometrial cancer who desire to preserve fertility.
